We were proud to
present the 24th Asia-Pacific Prostate Cancer Conference which returned to Melbourne in 2024. Over many years the conference has grown to
now be one of the largest comprehensive prostate cancer meetings in the
world.
As we stepped into
2024, the global impact of prostate cancer continued to expand. Novel
therapies for the treatment of advanced disease have seemed to multiply
exponentially. The conference focused on the latest innovations in
prostate cancer research, including the advancement of precision
medicine and targeted therapies, the integration of artificial
intelligence in the diagnostic algorithm and treatment pathways and the
development of next generation imaging techniques. We explored the
potential of genomics and immunotherapy in managing prostate cancer, as
well as role of theranostics, treatment sequencing and treatment
intensification. Additionally, the conference addressed aspects of
patient quality of life and survivorship, underscoring the importance of
holistic care in the journey of patient recovery.
We created a dynamic and invigorated scientific program with
both local and world leaders who brought their knowledge and
experience to discuss all facets of prostate cancer management,
treatment and scientific advancement. The gathering of experts served as a pivotal platform for sharing knowledge, fostering
collaboration and setting new directions in our quest to improve patient
outcomes in prostate cancer. We encouraged new research from home and
abroad to be shared. Beyond the structured scientific agenda, the
conference was designed to facilitate informal networking, creating an
atmosphere where attendees could forge relationships and exchange ideas in
a relaxed, social setting.
We were thrilled to
reunite in Melbourne after a five-year hiatus from our in-person
conference - It is a truly global city with leading research centres and
innovation at the forefront.
Supported By: